Dr. Jinsil Seong, Professor at
Yonsei University Medical College, is
honored for her ground-breaking work in primary liver
cancer
LOS ANGELES, April 8, 2019 /PRNewswire/ -- Blue Faery:
The Adrienne Wilson Liver Cancer Association is proud to announce
the annual Blue Faery Award (BFA) for Excellence in Liver Cancer
Research. Primary liver cancer, also known as Hepatocellular
Carcinoma (HCC), is the second leading cause of cancer deaths
worldwide. Blue Faery created the award to recognize medical
professionals who develop innovative research in HCC.
Upon receiving the BFA Dr. Jinsil
Seong stated, "I am truly honored and impressed to join
world leaders in [the] HCC field who won the award previously. This
encourages me to keep going forward for [a] better future of our
HCC patients!"
Professor Seong is one of a few who pioneered radiotherapy of
Hepatocellular Carcinoma. She has devoted her entire career on
radiotherapy of HCC by practicing, educating and pursuing clinical
research. With her enthusiasm and devotion overcoming a minority
issue not only in specialty (radiation oncology) but also in gender
(women), she has served as a president of the Korean Liver Cancer
Association. Additionally, she is the president-elect of the Asia
Pacific Primary Liver cancer Expert (APPLE) association, which is a
world leading liver cancer association.
President Andrea Wilson said, "We
are thrilled to give the BFA to Dr. Seong. Not only is she our
first international recipient, but she is also the first woman and
first radiation oncologist to win the BFA. She is changing the
landscape for HCC patients and providers." Andrea started Blue
Faery in honor of her sister Adrienne, who died of HCC at the age
of 15. Blue Faery announces the winner on April 8 –– Adrienne's birthday. She would have
been 33 years old this year.
Founded in 2002, the mission of Blue Faery is to prevent, treat
and cure primary liver cancer through research, education and
advocacy. Blue Faery's HCC patient education brochure is free for
patients, their families and their healthcare providers. To serve
the needs of HCC patients worldwide, Blue Faery's website
translates into 10 languages including Chinese, Hindi, Korean and
Spanish. Blue Faery hosts an online Liver Cancer Community for
patients and caregivers.
This press release was issued through 24-7PressRelease.com. For
further information, visit http://www.24-7pressrelease.com.
View original
content:http://www.prnewswire.com/news-releases/blue-faery-grants-liver-cancer-research-award-300825236.html
SOURCE Blue Faery